Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By

Generic Formulas X

Piroxicam Beta Cyclodextrin


Piroxicam-Beta-Cyclodextrin: A Complex Formulation for Enhanced Bioavailability

Piroxicam-beta-cyclodextrin is a complex formulation of piroxicam, a nonsteroidal anti-inflammatory drug (NSAID), with beta-cyclodextrin, a cyclic oligosaccharide. This complexation enhances the solubility and bioavailability of piroxicam, making it a more effective treatment option for various inflammatory conditions. 

Pharmacology

Piroxicam-beta-cyclodextrin works by forming a complex between piroxicam and beta-cyclodextrin, which enhances the solubility and bioavailability of piroxicam. This complexation allows for faster dissolution and absorption of piroxicam, leading to quicker onset of action and improved efficacy.

Clinical Use

Piroxicam-beta-cyclodextrin is used to treat various inflammatory conditions, including:

1. Osteoarthritis: Piroxicam-beta-cyclodextrin can be used to treat osteoarthritis, a condition characterized by joint pain and inflammation.

2. Rheumatoid arthritis: Piroxicam-beta-cyclodextrin can be used to treat rheumatoid arthritis, a chronic autoimmune disorder that causes inflammation and pain in the joints.

3. Ankylosing spondylitis: Piroxicam-beta-cyclodextrin can be used to treat ankylosing spondylitis, a condition characterized by inflammation and stiffness of the spine.

Benefits

Piroxicam-beta-cyclodextrin has several potential benefits, including:

1. Enhanced bioavailability: The complexation of piroxicam with beta-cyclodextrin enhances its bioavailability, leading to faster onset of action and improved efficacy.

2. Improved solubility: The complexation of piroxicam with beta-cyclodextrin improves its solubility, making it easier to absorb and utilize by the body.

3. Reduced gastrointestinal side effects: Piroxicam-beta-cyclodextrin may reduce gastrointestinal side effects compared to traditional piroxicam formulations.

Side Effects and Precautions

Piroxicam-beta-cyclodextrin can cause several side effects, including:

1. Gastrointestinal problems: Piroxicam-beta-cyclodextrin can cause gastrointestinal problems, such as stomach ulcers, bleeding, and perforation.

2. Cardiovascular problems: Piroxicam-beta-cyclodextrin can increase the risk of cardiovascular problems, such as heart attack and stroke.

3. Kidney problems: Piroxicam-beta-cyclodextrin can cause kidney problems, such as kidney damage and kidney failure.

Precautions and Contraindications

Certain precautions and contraindications should be considered when using piroxicam-beta-cyclodextrin, including:

1. Gastrointestinal disease: Piroxicam-beta-cyclodextrin should be used with caution in individuals with gastrointestinal disease, such as ulcers or bleeding.

2. Cardiovascular disease: Piroxicam-beta-cyclodextrin should be used with caution in individuals with cardiovascular disease, such as heart failure or hypertension.

3. Kidney disease: Piroxicam-beta-cyclodextrin should be used with caution in individuals with kidney disease, as it can exacerbate kidney problems.

Dosage and Administration

The dosage and administration of piroxicam-beta-cyclodextrin depend on the individual's needs and medical condition. The usual dose is 20 mg per day, although this can vary depending on the specific condition being treated.

Conclusion

Piroxicam-beta-cyclodextrin is a complex formulation that enhances the solubility and bioavailability of piroxicam, making it a more effective treatment option for various inflammatory conditions. While it can cause side effects and interact with other medications, it is a valuable treatment option for many individuals. By understanding the pharmacology, clinical use, and potential benefits of piroxicam-beta-cyclodextrin, healthcare providers can use it safely and effectively.

Recommendations for Future Research

1. Further studies on efficacy: Further studies are needed to fully understand the efficacy of piroxicam-beta-cyclodextrin in treating inflammatory conditions.

2. Comparative studies: Comparative studies are needed to evaluate the efficacy and safety of piroxicam-beta-cyclodextrin compared to other NSAIDs.

3. New indications: Research into new indications for piroxicam-beta-cyclodextrin may help to expand its clinical use.

Key Takeaways

1. Mechanism of action: Piroxicam-beta-cyclodextrin works by forming a complex between piroxicam and beta-cyclodextrin, enhancing its solubility and bioavailability.